 | • レポートコード：QYR9ST02893 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の胃腸治療及び診断市場について調査・分析し、以下の構成でお届け致します。胃腸治療及び診断の種類別には、診断、治療に、用途別には、病院薬局、小売薬局、オンライン薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別胃腸治療及び診断売上データ ・地域別胃腸治療及び診断市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別胃腸治療及び診断市場規模：診断、治療 ・用途別胃腸治療及び診断市場規模：病院薬局、小売薬局、オンライン薬局 ・主要メーカーの企業情報：Abbott Laboratories、Allergan、AstraZeneca、Bayer AG、GlaxoSmithKline、Janssen Pharmaceuticals、Takeda Pharmaceutical、Valeant Pharmaceuticals、Pfizer、AbbVie, Inc. ・胃腸治療及び診断の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.The global Gastrointestinal Therapeutics and Diagnostics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gastrointestinal Therapeutics and Diagnostics market based on company, product type, end user and key regions.
This report studies the global market size of Gastrointestinal Therapeutics and Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastrointestinal Therapeutics and Diagnostics in these regions.
This research report categorizes the global Gastrointestinal Therapeutics and Diagnostics market by top players/brands, region, type and end user. This report also studies the global Gastrointestinal Therapeutics and Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Allergan
AstraZeneca
Bayer AG
GlaxoSmithKline
Janssen Pharmaceuticals
Takeda Pharmaceutical
Valeant Pharmaceuticals
Pfizer
AbbVie, Inc.
Market size by Product
Diagnostics
Therapeutics
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Gastrointestinal Therapeutics and Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Gastrointestinal Therapeutics and Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastrointestinal Therapeutics and Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gastrointestinal Therapeutics and Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Gastrointestinal Therapeutics and Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastrointestinal Therapeutics and Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Gastrointestinal Therapeutics and Diagnostics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Product
1.4.2 Diagnostics
1.4.3 Therapeutics
1.5 Market by End User
1.5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size
2.1.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue 2014-2025
2.1.2 Global Gastrointestinal Therapeutics and Diagnostics Sales 2014-2025
2.2 Gastrointestinal Therapeutics and Diagnostics Growth Rate by Regions
2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales by Regions
2.2.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Gastrointestinal Therapeutics and Diagnostics Sales by Manufacturers
3.1.1 Gastrointestinal Therapeutics and Diagnostics Sales by Manufacturers
3.1.2 Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Manufacturers
3.1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Therapeutics and Diagnostics Revenue by Manufacturers
3.2.1 Gastrointestinal Therapeutics and Diagnostics Revenue by Manufacturers (2014-2019)
3.2.2 Gastrointestinal Therapeutics and Diagnostics Revenue Share by Manufacturers (2014-2019)
3.3 Gastrointestinal Therapeutics and Diagnostics Price by Manufacturers
3.4 Gastrointestinal Therapeutics and Diagnostics Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Therapeutics and Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Therapeutics and Diagnostics Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Therapeutics and Diagnostics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Gastrointestinal Therapeutics and Diagnostics Sales by Product
4.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Product
4.3 Gastrointestinal Therapeutics and Diagnostics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Gastrointestinal Therapeutics and Diagnostics Breakdown Data by End User
6 North America
6.1 North America Gastrointestinal Therapeutics and Diagnostics by Countries
6.1.1 North America Gastrointestinal Therapeutics and Diagnostics Sales by Countries
6.1.2 North America Gastrointestinal Therapeutics and Diagnostics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastrointestinal Therapeutics and Diagnostics by Product
6.3 North America Gastrointestinal Therapeutics and Diagnostics by End User
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics by Countries
7.1.1 Europe Gastrointestinal Therapeutics and Diagnostics Sales by Countries
7.1.2 Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal Therapeutics and Diagnostics by Product
7.3 Europe Gastrointestinal Therapeutics and Diagnostics by End User
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Therapeutics and Diagnostics by Countries
8.1.1 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales by Countries
8.1.2 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastrointestinal Therapeutics and Diagnostics by Product
8.3 Asia Pacific Gastrointestinal Therapeutics and Diagnostics by End User
9 Central & South America
9.1 Central & South America Gastrointestinal Therapeutics and Diagnostics by Countries
9.1.1 Central & South America Gastrointestinal Therapeutics and Diagnostics Sales by Countries
9.1.2 Central & South America Gastrointestinal Therapeutics and Diagnostics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastrointestinal Therapeutics and Diagnostics by Product
9.3 Central & South America Gastrointestinal Therapeutics and Diagnostics by End User
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics by Countries
10.1.1 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales by Countries
10.1.2 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics by Product
10.3 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics by End User
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Products Offered
11.1.5 Abbott Laboratories Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Allergan Gastrointestinal Therapeutics and Diagnostics Products Offered
11.2.5 Allergan Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 Company Business Overview
11.3.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Products Offered
11.3.5 AstraZeneca Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Company Business Overview
11.4.3 Bayer AG Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bayer AG Gastrointestinal Therapeutics and Diagnostics Products Offered
11.4.5 Bayer AG Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Gastrointestinal Therapeutics and Diagnostics Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Janssen Pharmaceuticals
11.6.1 Janssen Pharmaceuticals Company Details
11.6.2 Company Business Overview
11.6.3 Janssen Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Janssen Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Products Offered
11.6.5 Janssen Pharmaceuticals Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Company Business Overview
11.7.3 Takeda Pharmaceutical Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Takeda Pharmaceutical Gastrointestinal Therapeutics and Diagnostics Products Offered
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Valeant Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Valeant Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Products Offered
11.8.5 Valeant Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Gastrointestinal Therapeutics and Diagnostics Products Offered
11.9.5 Pfizer Recent Development
11.10 AbbVie, Inc.
11.10.1 AbbVie, Inc. Company Details
11.10.2 Company Business Overview
11.10.3 AbbVie, Inc. Gastrointestinal Therapeutics and Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AbbVie, Inc. Gastrointestinal Therapeutics and Diagnostics Products Offered
11.10.5 AbbVie, Inc. Recent Development
12 Future Forecast
12.1 Gastrointestinal Therapeutics and Diagnostics Market Forecast by Regions
12.1.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Regions 2019-2025
12.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Regions 2019-2025
12.2 Gastrointestinal Therapeutics and Diagnostics Market Forecast by Product
12.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Product 2019-2025
12.2.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Product 2019-2025
12.3 Gastrointestinal Therapeutics and Diagnostics Market Forecast by End User
12.4 North America Gastrointestinal Therapeutics and Diagnostics Forecast
12.5 Europe Gastrointestinal Therapeutics and Diagnostics Forecast
12.6 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Forecast
12.7 Central & South America Gastrointestinal Therapeutics and Diagnostics Forecast
12.8 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Therapeutics and Diagnostics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Gastrointestinal Therapeutics and Diagnostics Product Picture
Table Gastrointestinal Therapeutics and Diagnostics Market Segments
Table Key Manufacturers Gastrointestinal Therapeutics and Diagnostics Covered
Table Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product 2014-2025
Figure Diagnostics Product Picture
Table Major Manufacturers of Diagnostics
Figure Therapeutics Product Picture
Table Major Manufacturers of Therapeutics
Table Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Gastrointestinal Therapeutics and Diagnostics Sales 2014-2025 (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales by Regions 2014-2019 (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Regions 2014-2019
Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Regions 2014-2019
Figure 2018 Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Regions
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue by Regions 2014-2019 (Million US$)
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Regions
Table Global Gastrointestinal Therapeutics and Diagnostics Sales by Manufacturers (2014-2019) (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Share by Manufacturers (2014-2019)
Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Gastrointestinal Therapeutics and Diagnostics Revenue by Manufacturers (2014-2019) (Million USD)
Table Gastrointestinal Therapeutics and Diagnostics Revenue Share by Manufacturers (2014-2019)
Figure Gastrointestinal Therapeutics and Diagnostics Value Share by Manufacturers in 2018
Table Key Manufacturers Gastrointestinal Therapeutics and Diagnostics Price (2014-2019) (USD/Unit)
Table Gastrointestinal Therapeutics and Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gastrointestinal Therapeutics and Diagnostics Product Type
Table Date of International Manufacturers Enter into Gastrointestinal Therapeutics and Diagnostics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Therapeutics and Diagnostics Sales by Product (2014-2019) (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Share by Product (2014-2019)
Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product (2014-2019)
Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product in 2018
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue by Product (2014-2019) (Million US$)
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Product (2014-2019)
Figure Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Product (2014-2019)
Figure Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Product in 2018
Table Gastrointestinal Therapeutics and Diagnostics Price by Product 2014-2019 (USD/Unit)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales by End User (2014-2019) (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Share by End User (2014-2019)
Figure Global Sales Gastrointestinal Therapeutics and Diagnostics Market Share by End User (2014-2019)
Figure Global Sales Gastrointestinal Therapeutics and Diagnostics Market Share by End User in 2018
Figure North America Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure North America Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Gastrointestinal Therapeutics and Diagnostics Sales by Countries (2014-2019) (K Units)
Table North America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries
Table North America Gastrointestinal Therapeutics and Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table North America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries
Figure United States Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure United States Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Gastrointestinal Therapeutics and Diagnostics Sales by Product (2014-2019) (K Units)
Table North America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 North America Gastrointestinal Therapeutics and Diagnostics Market Share by Product
Table North America Gastrointestinal Therapeutics and Diagnostics Sales by End User (2014-2019) (K Units)
Table North America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 North America Gastrointestinal Therapeutics and Diagnostics Market Share by End User
Figure Europe Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Gastrointestinal Therapeutics and Diagnostics Sales by Countries (2014-2019) (K Units)
Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries
Table Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Europe Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries
Figure Germany Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure France Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure UK Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Gastrointestinal Therapeutics and Diagnostics Sales by Product (2014-2019) (K Units)
Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Product
Table Europe Gastrointestinal Therapeutics and Diagnostics Sales by End User (2014-2019) (K Units)
Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by End User
Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries
Figure China Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure China Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure India Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Product
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by End User
Figure Central & South America Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Sales by Countries (2014-2019) (K Units)
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries
Figure Brazil Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Sales by Product (2014-2019) (K Units)
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Share by Product
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Sales by End User (2014-2019) (K Units)
Table Central & South America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Gastrointestinal Therapeutics and Diagnostics Market Share by End User
Figure Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Countries
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Countries
Figure GCC Countries Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Product
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Share by End User
Table Abbott Laboratories Company Details
Table Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Allergan Company Details
Table Allergan Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Bayer AG Company Details
Table Bayer AG Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table AbbVie, Inc. Company Details
Table AbbVie, Inc. Gastrointestinal Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie, Inc. Recent Development
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Product 2019-2025 (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share Forecast by Product 2019-2025
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share Forecast by Product 2019-2025
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by End User 2019-2025 (K Units)
Table Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share Forecast by End User 2019-2025
Figure North America Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Gastrointestinal Therapeutics and Diagnostics Value Chain
Table Gastrointestinal Therapeutics and Diagnostics Customers List
Table Gastrointestinal Therapeutics and Diagnostics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
クラミジア感染診断・治療薬の世界市場：市場規模・現状・予測 The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities.In 2018, the global Chlamydia Infection Diagnostics and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ b…- 胃腸治療薬の世界市場：市場規模・現状・予測 Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarr…
- 胃腸障害治療薬の世界市場：市場規模・現状・予測 Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.Increasing incidences …
- 睡眠時無呼吸診断及び治療の世界市場：市場規模・現状・予測 Sleep apnea or Sleep disordered breathing (SDB) is a disorder that is characterised by brief interruptions in breathing or shallow breathing during sleep. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea.Sleep Apnea Diagnostics and Therapeutics are a serial of methods and medical…
- 睡眠時無呼吸診断及び治療の世界市場：市場規模・現状・予測 Sleep apnea or Sleep disordered breathing (SDB) is a disorder that is characterised by brief interruptions in breathing or shallow breathing during sleep. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea.Sleep Apnea Diagnostics and Therapeutics are a serial of methods and medical…